A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

Many healthcare and social services depend on international aid. Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and severe ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of antiretrovirals to one-month refills since the U.S. government froze foreign ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Philadelphia announced in 2020 that the city would be participating in an initiative to “end” the HIV epidemic by reducing ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...